Usefulness of Modified Intravenous Analgesia: Initial Experience in Uterine Artery Embolization for Leiomyomata.
10.3348/jkrs.2006.54.4.259
- Author:
Seung Boo YANG
1
;
Young Jin JUNG
;
Dong Erk GOO
;
Yun Woo JANG
Author Information
1. Department of Radiology, Soonchunhyang University, Gumi Hospital, Korea. ysbysb@sch.ac.kr
- Publication Type:Original Article
- Keywords:
Drug;
Drug side effect;
Uterine neoplasms;
Arteries, therapeutic embolization
- MeSH:
Analgesia*;
Back Pain;
Dyspnea;
Femoral Artery;
Humans;
Injections, Intramuscular;
Injections, Intravenous;
Ketorolac Tromethamine;
Leiomyoma;
Meperidine;
Oxygen;
Pain Management;
Passive Cutaneous Anaphylaxis;
Punctures;
Uterine Artery Embolization*;
Uterine Artery*;
Uterine Neoplasms
- From:Journal of the Korean Radiological Society
2006;54(4):259-264
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: We wanted to evaluate the usefulness of modified intravenous analgesia for the management of pain during uterine artery embolization for leiomyomata. MATERIALS AND METHODS: Between April 2004 and July 2004, 15 patients with symptomatic fibroids underwent uterine artery embolization and pain management. Except the three patients for whom the Visual Analogue Scale (VAS) score was not obtained, twelve patients were included in this study. For pain management, epidural PCA (Patient Controlled Analgesia) was used in two patients, intravenous PCA was used in two patients and modified intravenous analgesia injection was used in eight patients. For all the patients, we used the 2.8 Fr coaxial microcatheter and 500-710 μm PVA particles for the embolic materials. The protocol of the modified intravenous analgesia injection was as follow, 1) prior to femoral artery puncture, 30 mg of ketorolac tromethamine (Tarasyn) was injected via an intravenous route. 2) At the time that the one side uterine artery embolization was finished, normal saline mixed 150 mg meperidine (Demerol) was administered through the side port of the intravenous line that was used for hydration. 3) Additional ketorolac tromethamine 30 mg was injected after 6 hour. The VAS score and side effects were then checked. After 12 hours, the VAS score was rechecked. If the VAS score was above 4, this was considered as failure of pain management. The VAS scores, complications and side effects for the modified intravenous analgesia injection were compared with that of IV PCA and epidural PCA. RESULTS: The average VAS score of the modified intravenous analgesia injection, intravenous PCA and epidural PCA was 1.4, 1 and 0, respectively; the number of additional intramuscular injections of analgesia was 0.5, 0.5 and 0, respectively. All the patients who underwent epidural PCA had back pain at the puncture site and 1 patient who underwent modified intravenous analgesia injection experienced mild dyspnea, but they easily recovered with such conservative treatment as an oxygen supply. No serious side effects or complications developed from the modified intravenous analgesia injection. CONCLUSION: Modified intravenous analgesia injection is well tolerated for the pain management of uterine fibroid embolization and it is a relatively inexpensive, safe method as used in our radiologic practice.
